Related Research Articles
Anders Hallberg is a Swedish pharmaceutical researcher, professor in medicinal chemistry and 2006-2011 Rector Magnificus and Vice Chancellor at Uppsala University.
Saghir Akhtar is professor of pharmacology in the College of Medicine, Qatar University, and editor in chief of the Journal of Drug Targeting.
Joseph R. Robinson was a pharmacy researcher and the Edward Kremers Emeritus Professor of Pharmacy in the School of Pharmacy at the University of Wisconsin–Madison. He was particularly known for his work on ophthalmological drug delivery and on bioadhesion.
William Neil Charman is an Australian pharmaceutical scientist and pharmacist whose work has developed medical treatments in a range of areas, including a new drug for the treatment of malaria. He was also the founder and director of biomedical sciences company Acrux Ltd. He has published more than 320 scientific papers on his research and has received tens of millions of dollars in funding to further his work. Prior to embarking on a career in academic research, he worked for a number of pharmaceutical companies in the USA.
The University of Nottingham School of Pharmacy was founded in 1925 and is located in the University Park Campus of the university. The school also offers courses at the University's Malaysia campus in Kuala Lumpur with students spending two years in Malaysia and two years in Nottingham The School also offers the first joint Pharmacy course with China, with the Tianjin University of Traditional Chinese Medicine. The current head of The School is Professor Barrie Kellam (2021-).
Stanley Heptinstall is an Emeritus Professor of the University of Nottingham, Director of Platelet Solutions Ltd, and local government councillor on Nottinghamshire County Council.
Vladimir Petrovich Torchilin is a Soviet, Russian and American biochemist, pharmacologist, and an expert in medical nanotechnology. Torchillin is a University Distinguished Professor of Pharmaceutical Sciences at Northeastern University. He also serves as a director at both the Center for Translational Cancer Nanomedicine and at the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University.
Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.
Aliasger K. Salem is the Associate Vice President for Research at the University of Iowa and Bighley Chair and Professor of Pharmaceutical Sciences at the University of Iowa College of Pharmacy. Salem's academic appointment at the University of Iowa is based in the College of Pharmacy, with additional secondary appointments in the College of Dentistry, Department of Chemical and Biochemical Engineering, Department of Biomedical Engineering, Department of Chemistry, and the Holden Comprehensive Cancer Center. Prior to joining the University of Iowa in 2004, he was a postdoctoral fellow at the Johns Hopkins School of Medicine and completed his PhD at the School of Pharmacy and Pharmaceutical Sciences at the University of Nottingham in the UK.
Soodabeh Davaran is an Iranian researcher, and professor of polymer chemistry in the Faculty of Pharmacy in Tabriz University of Medical Sciences. She has written many articles about chemistry.
Bishnupada Mukerjee or Bishnupada Mukhopadhyaya was an Indian pharmacologist and orthopedic surgeon, known for his contributions in the fields of pharmacological research and standardization of drugs in India. The Government of India honoured him in 1962, with the award of Padma Shri, the fourth highest Indian civilian award for his services to the nation.
Stewart Sanders Adams was an English pharmacist, and bioengineer who was part of a team from Boots which developed the painkiller ibuprofen in 1961. Ibuprofen is now on the World Health Organization's Model List of Essential Medicines and is one of the world's best-selling drugs.
Harkishan Singh was Professor Emeritus at the Panjab University. He was a well recognized pharmaceutical academic, medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University, University of Saugar, and the Panjab University in India, and abroad at the University of Maryland, University of Mississippi and the University of London.
María José Alonso Fernandez is a full professor of biopharmaceutics and pharmaceutical technology at the University of Santiago de Compostela. The laboratory she leads is specialized in pharmaceutical nanotechnology and nanomedicine, and her research is oriented to the development of nanostructures for targeted delivery of drugs and vaccines. Her discoveries have led to significant clinical advances in the development of potential new treatments for cancer, ocular diseases, skin diseases, diabetes, obesity and other autoimmune pathologies, as well as new vaccines.
Ijeoma Uchegbu is a Nigerian-British Professor of Pharmacy at University College London where she held the position of Pro-Vice Provost for Africa and the Middle East. She is the Chief Scientific Officer of Nanomerics, a pharmaceutical nanotechnology company specialising in drug delivery solutions for poorly water-soluble drugs, nucleic acids and peptides. She is also a Governor of the Wellcome, a large biomedical research charity. Apart from her highly cited scientific research in Pharmaceutical Nanoscience, Uchegbu is also known for her work in science public engagement and equality and diversity in Science, Technology, Engineering and Mathematics (STEM).
Abdul Waseh Basit is a professor of pharmaceutics at University College London, and founder of two pharmaceutical biotechnology companies spinning out of UCL. Basit is interested in particular in oral drug delivery and pharmaceutical three-dimensional (3D) printing.
Johnson Nyarko Boampong is a Ghanaian pharmacist, biomedical Scientist, professor and the Vice-Chancellor of the University of Cape Coast.
Kishor M. Wasan is a Canadian pharmacologist, pharmacist and professor. He was the dean of the University of Saskatchewan's College of Pharmacy and Nutrition from 2014 to 2019 and associate dean of research and graduate studies at the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) from 2011 to 2014. Previously at UBC, he was chair of pharmaceutics and national director of the Canadian Summer Student Research Program after first joining the faculty in 1995. Wasan's research focuses on lipid-based drug delivery and the interaction between lipoprotein and pharmaceuticals. He has published more than 550 peer-reviewed articles and abstracts. He is a founding member and co-director of UBC's Neglected Global Diseases Initiative.
Meir Bialer is an Israeli pharmacologist who is a David H. Eisenberg Emeritus (active) Professor of Pharmacy at the School of Pharmacy, Faculty of Medicine, of The Hebrew University of Jerusalem in Israel.
Moein Moghimi is a British professor and researcher in the fields of nanomedicine, drug delivery and biomaterials. He is currently the professor of Pharmaceutics and Nanomedicine at the School of Pharmacy and research professor at the Institute of Cellular Medicine and the Translational and Clinical Research Institute at Newcastle University. He is also an adjoint professor at the Skaggs School of Pharmacy, University of Colorado Denver.
References
- 1 2 3 "Curriculum Vitae Professor Stanley (Bob) Davis". CosmasDamian Ltd.
- ↑ Akhtar, Saghir (December 2010). "In honor of Professor S. S. (Bob) Davis, Recipient of the Journal of Drug Targeting 's Life-time Achievement Award for 2010". Journal of Drug Targeting. 18 (10): 701. doi:10.3109/1061186X.2010.529268. PMID 21047270. S2CID 39202657.
